Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Arcadia Biosciences, Inc. ?
1
Poor Management Efficiency with a low ROE of 0.98%
- The company has been able to generate a Return on Equity (avg) of 0.98% signifying low profitability per unit of shareholders funds
2
Flat results in Sep 25
- NET PROFIT(HY) At USD -4.61 MM has Grown at -700.78%
- CASH AND EQV(HY) Lowest at USD 10.33 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -45.86%, its profits have risen by 6.6%
4
Below par performance in long term as well as near term
- Along with generating -45.86% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Arcadia Biosciences, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Arcadia Biosciences, Inc.
-45.89%
-0.40
100.06%
S&P 500
13.68%
0.71
19.28%
Quality key factors
Factor
Value
Sales Growth (5y)
31.40%
EBIT Growth (5y)
10.49%
EBIT to Interest (avg)
-16.36
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.35
Sales to Capital Employed (avg)
0.60
Tax Ratio
1.05%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.99%
ROCE (avg)
0
ROE (avg)
0.98%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.56
EV to EBIT
0.32
EV to EBITDA
0.33
EV to Capital Employed
2.84
EV to Sales
-0.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
889.80%
ROE (Latest)
-90.89%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Movement
12What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -6.09 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 2.81 times
DEBT-EQUITY RATIO
(HY)
Lowest at -108.12 %
PRE-TAX PROFIT(Q)
Highest at USD 0.3 MM
NET PROFIT(Q)
Highest at USD 0.3 MM
-10What is not working for the Company
NET PROFIT(HY)
At USD -4.61 MM has Grown at -700.78%
CASH AND EQV(HY)
Lowest at USD 10.33 MM
Here's what is working for Arcadia Biosciences, Inc.
Operating Cash Flow
Highest at USD -6.09 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Pre-Tax Profit
At USD 0.3 MM has Grown at 117.55%
over average net sales of the previous four periods of USD -1.69 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 0.3 MM has Grown at 117.53%
over average net sales of the previous four periods of USD -1.69 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Inventory Turnover Ratio
Highest at 2.81 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Pre-Tax Profit
Highest at USD 0.3 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 0.3 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Debt-Equity Ratio
Lowest at -108.12 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Arcadia Biosciences, Inc.
Cash and Eqv
Lowest at USD 10.33 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents






